Please login to the form below

Not currently logged in

Treatment Investigational New Drug (IND)

A regulation in the US which attempts to give seriously ill patients access to new developmental drugs as early as possible. These drugs are generally made available during phase III studies before general marketing begins.

See also:
Compassionate use
Experimental drug
Phase III trials

Your comments about Treatment Investigational New Drug (IND):

Your name:
Your email:

COVID-19 Updates and Daily News

Featured jobs


Add my company
Graphite Digital

We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences...